MSS/ MMRp

我们是谁

  • 1 月 17, 2024
    In Vivo Lung Perfusion (IVLP) for Colorectal Cancer Metastatic to Lung
  • 1 月 17, 2024
    A Study Investigating the Efficacy and Safety of LBL-007 Plus Tislelizumab in Combination With Bevacizumab Plus Capecitabine Versus Bevacizumab Plus Capecitabine in Participants With Unresectable or Metastatic Colorectal Cancer
  • 1 月 12, 2024
    A Study of QBECO Versus Placebo in the Treatment of Colorectal Cancer That Has Spread to the Liver
  • 1 月 12, 2024
    联合免疫疗法方案的 I/II 期研究：治疗转移性结直肠癌 (mCRC) 的联合免疫疗法方案：SX-682、TriAdeno 疫苗、雷替凡利单抗和 IL-15 激动剂 N-803 (STAR15)
  • 1 月 10, 2024
    INCB099280 联合 Adagrasib 治疗携带 KRASG12C 突变的晚期实体瘤成人研究
  • 1 月 9, 2024
    ERASur研究：测试在有限转移性结直肠癌的常规系统疗法基础上增加全烧蚀疗法的效果
  • 1 月 8, 2024
    TAS-102 加放射疗法治疗结直肠癌肝转移患者肝脏的研究
  • 1 月 8, 2024
    M9241 与肝动脉输注泵 (HAIP) 和全身疗法联合用于转移性结直肠癌或肝内胆管癌患者的治疗
  • 1 月 8, 2024
    评估自体钙粘蛋白 17 嵌合抗原受体 (CAR) T 细胞疗法 CHM-2101 的 1/2 期研究
  • 1 月 8, 2024
    Postoperative Chemotherapy With/Without Radiotherapy and Immunotherapy for Colorectal Liver Metastases With High Risk of Locally Recurrence